InMed Pharmaceuticals Inc. Annual Amortization of Intangible Assets in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
InMed Pharmaceuticals Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2020 to 2024.
  • InMed Pharmaceuticals Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $41K, unchanged year-over-year.
  • InMed Pharmaceuticals Inc. annual Amortization of Intangible Assets for 2024 was $172K, a 7.93% increase from 2023.
  • InMed Pharmaceuticals Inc. annual Amortization of Intangible Assets for 2023 was $159K, unchanged from 2022.
  • InMed Pharmaceuticals Inc. annual Amortization of Intangible Assets for 2022 was $159K, a 59.7% increase from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $172K +$12.6K +7.93% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-30
2023 $159K $0 0% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-30
2022 $159K +$59.5K +59.7% Jul 1, 2021 Jun 30, 2022 10-K 2022-09-23
2021 $99.7K +$12.1K +13.9% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-23
2020 $87.6K Jul 1, 2019 Jun 30, 2020 10-K 2021-09-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.